Results 191 to 200 of about 47,485 (252)
Some of the next articles are maybe not open access.
Expert Opinion on Emerging Drugs, 2007
Anxiety disorders are the most common of the psychiatric disorders and are also associated with significant economic costs and impaired work productivity. The first-line pharmacotherapy of pharmatherapy for a number of anxiety disorders comprises selective serotonin re-uptake inhibitors (SSRIs) and serotonin and noradrenaline re-uptake inhibitors ...
Nirvana S, Pillay, Dan J, Stein
openaire +2 more sources
Anxiety disorders are the most common of the psychiatric disorders and are also associated with significant economic costs and impaired work productivity. The first-line pharmacotherapy of pharmatherapy for a number of anxiety disorders comprises selective serotonin re-uptake inhibitors (SSRIs) and serotonin and noradrenaline re-uptake inhibitors ...
Nirvana S, Pillay, Dan J, Stein
openaire +2 more sources
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1985
Sixty (60) out-patients with DSM III generalized anxiety disorder were treated after a 1-week placebo washout in a 4-week double-blind study with buspirone, diazepam and placebo; after which they were withdrawn abruptly from medication or assigned to a 2-week period of placebo.
J C, Pecknold +5 more
openaire +2 more sources
Sixty (60) out-patients with DSM III generalized anxiety disorder were treated after a 1-week placebo washout in a 4-week double-blind study with buspirone, diazepam and placebo; after which they were withdrawn abruptly from medication or assigned to a 2-week period of placebo.
J C, Pecknold +5 more
openaire +2 more sources
Nihon rinsho. Japanese journal of clinical medicine, 2012
This chapter outlines the clinician' s guide for prescription of benzodiazepine anxiolytics and 5-HT1A receptor agonists. 5-HT1A receptor agonists have entirely different pharmacological mechanism of action from benzodiazepines, and the pattern of their use is quite different from benzodiazepines.
Keiichiro, Tsuji, Osamu, Tajima
openaire +3 more sources
This chapter outlines the clinician' s guide for prescription of benzodiazepine anxiolytics and 5-HT1A receptor agonists. 5-HT1A receptor agonists have entirely different pharmacological mechanism of action from benzodiazepines, and the pattern of their use is quite different from benzodiazepines.
Keiichiro, Tsuji, Osamu, Tajima
openaire +3 more sources